Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Galantamine 16mg modified-release capsules
0411000F0AAAFAF
|
Galantamine | Galantamine | Central Nervous System | 6,586 |
|
Gatalin XL 24mg capsules
0411000F0BFACAG
|
Gatalin XL | Galantamine | Central Nervous System | 5,093 |
|
Gatalin XL 16mg capsules
0411000F0BFABAF
|
Gatalin XL | Galantamine | Central Nervous System | 4,717 |
|
Galantamine 24mg modified-release capsules
0411000F0AAAGAG
|
Galantamine | Galantamine | Central Nervous System | 4,243 |
|
Galantamine 8mg modified-release capsules
0411000F0AAAEAE
|
Galantamine | Galantamine | Central Nervous System | 2,794 |
|
Gazylan XL 16mg capsules
0411000F0BKABAF
|
Gazylan XL | Galantamine | Central Nervous System | 2,760 |
|
Galzemic XL 16mg capsules
0411000F0BIABAF
|
Galzemic | Galantamine | Central Nervous System | 2,504 |
|
Luventa XL 16mg capsules
0411000F0BJABAF
|
Luventa XL | Galantamine | Central Nervous System | 2,361 |
|
Gazylan XL 24mg capsules
0411000F0BKACAG
|
Gazylan XL | Galantamine | Central Nervous System | 1,863 |
|
Gatalin XL 8mg capsules
0411000F0BFAAAE
|
Gatalin XL | Galantamine | Central Nervous System | 1,540 |
|
Luventa XL 24mg capsules
0411000F0BJACAG
|
Luventa XL | Galantamine | Central Nervous System | 1,275 |
|
Galzemic XL 24mg capsules
0411000F0BIACAG
|
Galzemic | Galantamine | Central Nervous System | 1,247 |
|
Galantamine 20mg/5ml oral solution sugar free
0411000F0AAADAD
|
Galantamine | Galantamine | Central Nervous System | 1,129 |
|
Galzemic XL 8mg capsules
0411000F0BIAAAE
|
Galzemic | Galantamine | Central Nervous System | 913 |
|
Gazylan XL 8mg capsules
0411000F0BKAAAE
|
Gazylan XL | Galantamine | Central Nervous System | 889 |
|
Luventa XL 8mg capsules
0411000F0BJAAAE
|
Luventa XL | Galantamine | Central Nervous System | 591 |
|
Galzemic 4mg/ml oral solution
0411000F0BIADAD
|
Galzemic | Galantamine | Central Nervous System | 229 |
|
Reminyl XL 24mg capsules
0411000F0BBAHAG
|
Reminyl | Galantamine | Central Nervous System | 119 |
|
Reminyl 4mg/ml oral solution
0411000F0BBAEAD
|
Reminyl | Galantamine | Central Nervous System | 62 |
|
Galantamine 8mg tablets
0411000F0AAABAB
|
Galantamine | Galantamine | Central Nervous System | 35 |
|
Reminyl XL 16mg capsules
0411000F0BBAGAF
|
Reminyl | Galantamine | Central Nervous System | 33 |
|
Reminyl XL 8mg capsules
0411000F0BBAFAE
|
Reminyl | Galantamine | Central Nervous System | 28 |
|
Gaalin 16mg modified-release capsules
0411000F0BMABAF
|
Gaalin | Galantamine | Central Nervous System | 17 |
|
Lotprosin XL 16mg capsules
0411000F0BGABAF
|
Lotprosin XL | Galantamine | Central Nervous System | 16 |
|
Consion XL 16mg capsules
0411000F0BLABAF
|
Consion XL | Galantamine | Central Nervous System | 11 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.